M-A: Convalescent plasma does not reduce mortality in COVID-19.
Association between convalescent plasma treatment and mortality in COVID-19: a collaborative systematic review and meta-analysis of randomized clinical trials – BMC Infectious Diseases Related: RCT: Another study shows convalescent plasma does not improve outcomes in critically ill patients with Covid-19. RCT: Convalescent plasma does not improve outcomes and may be harmful to hospitalized patients with […]
The post M-A: Convalescent plasma does not reduce mortality in COVID-19. appeared first on Links Medicus.
Estimation of SARS-CoV-2 infection fatality rate by age and comorbidity status using antibody screening of blood donors during the COVID-19 epidemic in Denmark – “The IFR was low for people younger than 51 years without comorbidity during the two waves (c
Estimation of SARS-CoV-2 infection fatality rate by age and comorbidity status using antibody screening of blood donors during the COVID-19 epidemic in Denmark – The Journal of Infectious Diseases Commentary on Twitter New in JID: A study in Denmark found that the SARS-CoV-2 infection fatality rate was low for people younger than 51 and […]
The post Estimation of SARS-CoV-2 infection fatality rate by age and comorbidity status using antibody screening of blood donors during the COVID-19 epidemic in Denmark – “The IFR was low for people younger than 51 years without comorbidity during the two waves (combined IFR = 3.36 per 100,000 infections)”. appeared first on Links Medicus.
EuGMS Guidance: Management of post-acute COVID-19 patients in geriatric rehabilitation.
Management of post-acute COVID-19 patients in geriatric rehabilitation: EuGMS guidance – European Geriatric Medicine Related: Addressing Post-COVID Symptoms: A Guide for Primary Care Physicians. Global surveillance, research, and collaboration needed to improve understanding and management of long COVID. Provocative study suggests that persistent physical symptoms after COVID-19 infection may be associated more with the belief […]
The post EuGMS Guidance: Management of post-acute COVID-19 patients in geriatric rehabilitation. appeared first on Links Medicus.
Non-invasive respiratory support in the management of acute COVID-19 pneumonia: considerations for clinical practice and priorities for research – “The two randomized controlled trials indicate superiority of non-invasive ventilation over high-flow nasal
Non-invasive respiratory support in the management of acute COVID-19 pneumonia: considerations for clinical practice and priorities for research – The Lancet Respiratory Medicine Related: [Preprint] RCT: non-invasive respiratory strategies in acute respiratory failure in patients with COVID-19 – CPAP reduced the composite outcome of intubation or death within 30 days; high-flow nasal oxygenation was not associated […]
The post Non-invasive respiratory support in the management of acute COVID-19 pneumonia: considerations for clinical practice and priorities for research – “The two randomized controlled trials indicate superiority of non-invasive ventilation over high-flow nasal oxygen in reducing the need for intubation”. appeared first on Links Medicus.
United States FDA clears COVID vaccine boosters for all adults over 18 – Pfizer & Moderna 6 months after second jab.
United States FDA Clears COVID Vaccine Boosters for All Adults Over 18 – Pfizer & Moderna 6 Months After Second Jab – Health Policy Watch See also: FDA expands emergency authorization for Covid-19 booster shots to all adults – STAT FDA, CDC advisors approve COVID boosters for all US adults – CIDRAP FDA Approves Both […]
The post United States FDA clears COVID vaccine boosters for all adults over 18 – Pfizer & Moderna 6 months after second jab. appeared first on Links Medicus.
AAP Clinical Report: Biologics for Asthma and Allergic Skin Diseases in Children.
Biologics for Asthma and Allergic Skin Diseases in Children – Pediatrics
The post AAP Clinical Report: Biologics for Asthma and Allergic Skin Diseases in Children. appeared first on Links Medicus.
WHO global report on trends in prevalence of tobacco use 2000-2025.
WHO global report on trends in prevalence of tobacco use 2000-2025, fourth edition – World Health Organization News Release: Tobacco use falling: WHO urges countries to invest in helping more people to quit tobacco – World Health Organization Commentary on Twitter Tobacco use is falling by 5⃣ million people per year ? WHO global […]
The post WHO global report on trends in prevalence of tobacco use 2000-2025. appeared first on Links Medicus.
RECOVERY Trial: Aspirin as an add-on therapy did not reduce mortality in patients hospitalized with COVID-19.
Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial – The Lancet Invited Commentary: Studying the coagulopathy of COVID-19 – The Lancet Commentary from the author on Twitter (thread – click for more) RECOVERY Publication: ASPIRIN(a widely used anti-platelet treatment in other settings) 14 892 patients hospitalised with COVID-19. […]
The post RECOVERY Trial: Aspirin as an add-on therapy did not reduce mortality in patients hospitalized with COVID-19. appeared first on Links Medicus.
[Preprint] M-A: Inhaled corticosteroids in COVID-19 outpatients.
Inhaled Corticosteroids for Outpatients with Covid-19: A Meta-Analysis – medRxiv Commentary: Favourable meta-analysis of inhaled corticosteroids in COVID-19 outpatients – News Medical Related: PRINCIPLE RCT: Inhaled budesonide improves time to recovery from COVID-19 in people at high risk of complications in the community. Position Paper: Recommendations for the use of topical inhalant budesonide in COVID-19. […]
The post [Preprint] M-A: Inhaled corticosteroids in COVID-19 outpatients. appeared first on Links Medicus.
Observational study finds the effectiveness of mRNA vaccination against Covid-19 hospitalization was lower (77%) among immunocompromised adults than among immunocompetent adults (90%).
Effectiveness of 2-Dose Vaccination with mRNA COVID-19 Vaccines Against COVID-19–Associated Hospitalizations Among Immunocompromised Adults — Nine States, January–September 2021 – CDC Morbidity and Mortality Weekly Report Related: CDC Guidance: Immunocompromised may need a fourth Covid-19 shot. Commentary on Twitter (thread – click for more) New CDC study of mRNA #vaccination & disease in 89,000 […]
The post Observational study finds the effectiveness of mRNA vaccination against Covid-19 hospitalization was lower (77%) among immunocompromised adults than among immunocompetent adults (90%). appeared first on Links Medicus.